MEG3 and non-small cell lung carcinoma: In addition, cell line experiments demonstrated that lncRNA MEG3 could serve as a predictor of palbociclib sensitivity in NSCLC in that the expression of MEG3 was positively correlated with phosphorylated Rb protein and suppressed cell cycle [44].